Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for GoodRx Holdings, Inc. (GDRX : NSDQ)

• Company Description    GoodRx Holdings Inc. provides consumer-focused digital healthcare platform. GoodRx Holdings Inc. is based in Santa Monica, California. Number of Employees: 738

• Price / Volume Information    Yesterday's Closing Price: $4.74 Daily Weekly Monthly 20 Day Moving Average: 1,460,049 shares Shares Outstanding: 357.17 (millions) Market Capitalization: $1,694.77 (millions) Beta: 1.24 52 Week High: $9.26 52 Week Low: $3.68 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 8.58% 3.68% 12 Week 5.80% -10.72% Year To Date 2.04% -4.12%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2701 OLYMPIC BOULEVARD - SANTA MONICA,CA 90404 USA ph: 855-268-2822 fax: - ir@goodrx.com http://www.goodrx.com

• General Corporate Information    Officers Wendy Barnes - Chief Executive Officer; President and Director Trevor Bezdek - Chairman Christopher McGinnis - Chief Financial Office Romin Nabiey - Chief Accounting Office Christopher Adams - Director Peer Information GoodRx Holdings, Inc. (CHCR) GoodRx Holdings, Inc. (ESRX) GoodRx Holdings, Inc. (MYDP) GoodRx Holdings, Inc. (COR) GoodRx Holdings, Inc. (GBCS) GoodRx Holdings, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 38246G108 SIC: 7374 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/06/25 Share - Related Items Shares Outstanding: 357.17 Most Recent Split Date: (:1) Beta: 1.24 Market Capitalization: $1,694.77 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.05 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.20 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 11.10% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/06/25

• Fundamental Ratios P/E Current FY Estimate: 23.43 Trailing 12 Months: 33.89 PEG Ratio: 2.11 Price Ratios Price/Book: 2.59 Price/Cash Flow: 14.91 Price / Sales: 2.13 EPS Growth vs. Year Ago Period: 66.67% vs. Previous Quarter: 25.00% Sales Growth vs. Year Ago Period: 2.57% vs. Previous Quarter: 2.21% ROE 06/30/25 - - 03/31/25 - 7.85 12/31/24 - 7.02 ROA 06/30/25 - - 03/31/25 - 3.91 12/31/24 - 3.37 Current Ratio 06/30/25 - - 03/31/25 - 5.23 12/31/24 - 5.32 Quick Ratio 06/30/25 - - 03/31/25 - 5.23 12/31/24 - 5.32 Operating Margin 06/30/25 - - 03/31/25 - 6.75 12/31/24 - 6.03 Net Margin 06/30/25 - - 03/31/25 - 3.57 12/31/24 - 2.07 Pre-Tax Margin 06/30/25 - - 03/31/25 - 6.00 12/31/24 - 3.97 Book Value 06/30/25 - - 03/31/25 - 1.83 12/31/24 - 1.89 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 0.74 12/31/24 - 0.67 Debt-to-Capital 06/30/25 - - 03/31/25 - 42.61 12/31/24 - 40.18

Powered by Zacks Investment Research ©